NCT07042919 2025-06-29Zanzalintinib in Second Line and Beyond for the Treatment of Advanced Liver CancerNorthwestern UniversityPhase 1/2 Not yet recruiting53 enrolled
NCT05586516 2025-03-20A Study to Assess an ATX Inhibitor (IOA-289) in Patients with Metastatic Pancreatic CanceriOncturaPhase 1/2 Active not recruiting24 enrolled